IMU Ann: FDA clears Imugene IND for onCARlytics first-in-class study - 19th May 2023, 8:35am

[annb0t]

IMU Ann: FDA clears Imugene IND for onCARlytics first-in-class study
Price Sensitive: Y
Date: 19th May 2023, 8:35am

>>> Read announcement: Google: IMU Market Announcements